- Home
- BRBS vs SLP Comparison
BRBS vs SLP Comparison
Compare BRBS & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRBS | SLP |
|---|---|---|
| Founded | 1893 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.8M | 370.7M |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BRBS | SLP |
|---|---|---|
| Price | $3.94 | $18.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | ★ 720.1K | 343.0K |
| Earning Date | 04-23-2026 | 04-09-2026 |
| Dividend Yield | ★ 24.78% | N/A |
| EPS Growth | ★ 135.48 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $111,284,000.00 | $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ N/A | $42.70 |
| Revenue Growth | ★ 123.99 | 10.52 |
| 52 Week Low | $3.23 | $11.09 |
| 52 Week High | $4.79 | $21.01 |
Technical Indicators
Market Signals| Indicator | BRBS | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 70.37 | 61.92 |
| Support Level | $3.26 | $18.20 |
| Resistance Level | $4.12 | $18.39 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 83.19 | 73.68 |
Price Performance
Historical ComparisonAbout BRBS Blue Ridge Bankshares Inc.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.